Author:
Rizzo Francesca Romana,Bruno Antonio,Federici Mauro,Mercuri Nicola Biagio
Publisher
Springer International Publishing
Reference71 articles.
1. Abdallah CG, Averill LA, Akiki TJ, Raza M, Averill CL, Gomaa H, Adikey A, Krystal JH (2019) The neurobiology and pharmacotherapy of posttraumatic stress disorder. Annu Rev Pharmacol Toxicol 6(59):171–189. https://doi.org/10.1146/annurev-pharmtox-010818-021701. Epub 2018 Sep 14. PMID: 30216745; PMCID: PMC6326888
2. NIDA research monograph 22;GM Anderson,1978
3. Bahji A, Forsyth A, Groll D, Hawken ER (2020) Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: a systematic review and meta-analysis. Prog Neuro-Psychopharmacol Biol Psychiatry 10(96):109735. https://doi.org/10.1016/j.pnpbp.2019.109735
4. Bristol Imperial MDMA in Alcoholism Study (2020). https://clinicaltrials.gov/ct2/show/NCT04158778?term=mdma&cond=Alcohol+Use+Disorder&draw=2&rank=1)
5. Cami J, Farré M, Mas M, Roset PN, Poudevida S, Mas A, San L, De La Torre R (2000) Human pharmacology of 3,4-methylenedioxymethamphetamine (“ecstasy”): psychomotor performance and subjective effects. J Clin Psychopharmacol 20